Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines

• Published in: Chemical & pharmaceutical bulletin Vol. 66; no. 6; pp. 612 - 619
• Main Authors: Zhang, Qijing, Dong, Jinyun, Cui, Jiahua, Huang, Guang, Meng, Qingqing, Li, Shaoshun
• Format: Journal Article
• Language: English; Japanese
• Published: Japan The Pharmaceutical Society of Japan 01.06.2018; Pharmaceutical Society of Japan
• Subjects: anticancer agent; cytotoxicity; naphthoquinone; oxime; naphthoquinone; oxime; anticancer agent; cytotoxicity
• ISSN: 0009-2363; 1347-5223
• DOI: 10.1248/cpb.c18-00013

In an effort to develop potent and selective antitumor agents, a series of 1,4-naphthoquinone oxime derivatives were designed and synthesized. The cytotoxicity of these compounds were evaluated against five human cancer cell lines (colorectal cancer cell: HCT-15, breast cancer cell: MDA-MB-231, liver cancer cell: BEL-7402, colorectal cancer cell: HCT-116 and ovarian cancer cell: A2780) in vitro. Among them, compound 14 was found to be the most potent cytotoxic compound against three cell lines (MDA-MB-231, BEL-7402 and A2780) with IC50 values of 0.66±0.05, 5.11±0.12 and 8.26±0.22 µM, respectively. Additionally, the length of the side chains and the position of the substituent may also affect the cytotoxic activity of the naphthoquinone oxime derivatives. In general, compound 14 effectively inhibited breast cancer cell proliferation and may become a promising anticancer agent.